Avid Bioservices Inc (CDMO)

[biopharm]

Dr. Edelman - Univ. of MD speaks looking forward to working with Bavituximab

Dr. Martin Edelman: "I look forward to being involved in the upcoming Phase III trial and to seeing the potential of bavituximab in other indications and combinations," said Martin J. Edelman, M.D., Professor of Medicine at the University of Maryland Greenebaum Cancer Center

https://www.facebook.com/UMGCC/posts/10151727035615439

I was glad to hear Dr. Martin Edelman talk about the upcoming Phase III = The SunRise Trial and this facebook page may get a lot of comments now and here is a video link of Dr. Martin Edelman talking about lung cancer: see 7 min 28 sec mark of the video
--------------------------------------------------------------

Now... unfortunately some Big Pharma will not have the opportunity to test some of their drugs or downstream agents with Bavituximab because I don't see Peregrine Pharmaceuticals partnering with more than one BP for a single indication.... time is a ticking and may the best BP walk in Peregrines path.

GLTA!